Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 25

Posts Tagged ‘system’

Innovusion to Release a New LiDAR System More Advanced Than Human Sight, “Falcon”

Posted by fidest press agency su mercoledì, 8 gennaio 2020

Innovusion Inc. is a worldwide leader in the design and development of long-range image-grade LiDAR (Light Detection and Ranging) systems for vehicle safety applications. Following the success of its predecessors, “Cheetah” and “Jaguar,” Innovusion will be unveiling the most advanced LiDAR system “Falcon” at CES 2020, where perception software will have LiDAR systems that surpass the human eye. Innovusion LiDAR systems are built by fusing together proprietary detector electronics, advanced optics, and sophisticated software algorithms and are designed from the ground up to meet the highly competitive pricing for automotive ADAS systems. With a vertical and horizontal resolution of 0.07 degrees at 10 frames per second and a field of view of 110 degrees x 30 degrees, Falcon will enable all vehicle makers to capture complex visuals at a greater distance and fulfill the demanding needs for perception software development that was not previously possible.“As an industry, we need to do everything we can to make driving safer, whether it is autonomous or not. Our LiDARs are able to see through heavy rain, intelligently steer focal points for efficient object perception and simultaneous localization and mapping (SLAM), and reliably detect even very small obstacles at very long distance,” said Junwei Bao, Co-Founder and CEO of Innovusion. “The launch of Falcon is a milestone for the automotive industry overall, allowing vehicle perception software to have greater clarity and capability to predict object behavior with the high-density point cloud at long distance regardless of light and distance. Our continued efforts to improve technology will increase adoption and acceptance of LiDAR technology with consumers.” Falcon combines ultra-long-range distance detection with image grade resolution, resulting in a detection detail of 40 points on a pedestrian that is 120 meters away while simultaneously maintaining a high frame rate and high resolution for the entire 110-degree field of view. With Falcon, the LiDAR can hone in on an object without sacrificing detail or clarity on the entire range of vision. Innovusion’s LiDARs have many different applications. Metropolitan cities in Asia use Falcon’s predecessors for intersection safety monitoring and other smart transportation applications. Future plans include additional partnerships with public transportation authorities to help increase the safety and reliability of legacy transit systems.Innovusion will be debuting Falcon at CES 2020 from January 7-10 in Las Vegas at the Convention Center, Booth 9026 located at Tech East, North Hall.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of Clinical Feasibility Study to Evaluate RECELL System for Vitiligo

Posted by fidest press agency su martedì, 31 dicembre 2019

AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application to conduct a feasibility study evaluating the safety and effectiveness of the RECELL® Autologous Cell Harvesting Device (RECELL® System) for repigmentation of depigmented lesions associated with stable vitiligo.
“Vitiligo affects approximately 6.5 million people in the United States(i), rivalling the prevalence of psoriasis(ii); however, there are limited treatment options available to patients to permanently restore skin pigmentation,” said Dr. Mike Perry, AVITA Medical Chief Executive Officer. “We’re pleased with the FDA’s decision which allows us to begin our vitiligo study in the first half of 2020. Based on the outcomes of the feasibility study, we anticipate proceeding with a pivotal clinical trial to pursue FDA approval of the RECELL System as a cell-based repigmentation treatment option for stable vitiligo.”Vitiligo is a disease resulting in loss of color, or pigmentation, in patches of skin that impacts the quality of life for those living with the condition.(iii) There is currently no cure for vitiligo, nor a universally accepted method for limiting the spread of the disease. Although many treatments are being used for the management of vitiligo, they are often temporary with a high rate of recurrence.(iv)“This study expands on peer-reviewed, published effectiveness outcomes to confirm the feasibility of RECELL as a treatment for repigmentation in cases of stable vitiligo,” said Andy Quick, AVITA Medical’s Chief Technology Officer. “Given the RECELL System’s broad approval outside of the U.S., more than 1,000 vitiligo patients have already been treated globally and reported repigmentation.”AVITA Medical will collaborate with a leading medical center to conduct a pilot study with 10 patients who have vitiligo lesions that have been stable for at least one year. Areas of the vitiligo lesion will be randomly treated with slightly varying cell suspensions prepared using RECELL to confirm response rates and optimal suspension parameters.The randomized controlled study’s primary effectiveness measure is the percent area of repigmented skin 24 weeks after treatment, as evaluated by a clinician blinded to the treatment assignment. Additional effectiveness data collected over the course of the 24-week study will include degree of repigmentation achieved and patient rating of repigmentation.

Posted in Estero/world news, Uncategorized | Contrassegnato da tag: , , , | Leave a Comment »

Stibo Systems to Host MDM Conference in Melbourne

Posted by fidest press agency su giovedì, 21 novembre 2019

Stibo Systems, the only master data management (MDM) company focused on putting Your business first has announced its Master Data Management Conference in Melbourne, Australia, on November 28th at the Treetops Venue, Melbourne Museum.
The conference provides a forum for business leaders across all industries to be at the nexus of ideas and policies that will impact the MDM marketplace. Attendees will explore critical topics such as industry data challenges, change enablement and readiness, customer centric design and protecting customer privacy.“Today, mobile, AI, the cloud, big data, blockchain, robotics and virtual reality are just a few of the rapidly-evolving technologies companies everywhere are being required to understand and master,” says Manfred Heckt, Managing Director, Stibo Systems Pty. Ltd. “Our keynote will explore this topic, and how business leaders need to transform their own skills in order to survive and thrive in this new digital world.” Speakers at the event include: Keynote speaker, Stephen Scheeler, ‘The Digital CEO’; Neil Cresswell, Chief Information Officer, NXP; David Littlewood, Head of Information and Analytics, GPC/Repco; Jonathan Moeller, Founder, foryouandyourcustomers and Stefan Conrad, Merchandise Process and Support Manager, Officeworks.
The one-day event also features a full slate of Stibo Systems’ leadership, discussing recent developments in our Digital Business Hub strategy, the company’s plans for continued growth and innovation across the seamlessly integrated suite of multidomain MDM solutions, as well as continued innovations in cloud, machine learning and artificial intelligence.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Installation of IntelliSpace Critical Care and Anesthesia system

Posted by fidest press agency su domenica, 17 novembre 2019

Amsterdam, the Netherlands and Jakarta, Indonesia – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a significant development in the digitization of patient treatment in Indonesia, with the country’s first installation of Philips IntelliSpace Critical Care and Anesthesia (ICCA) system at the Kasih Ibu Hospital in Denpasar, Bali. The critical care technology is part of Philips’ broader connected care suite aimed to help ensure seamless care and timely information flow between patients and the healthcare professionals who provide treatment. At Kasih Ibu Hospital, the critical care system will be integrated with Philips Patient Deterioration Solution – a portfolio of solutions to help manage patient deterioration outside the ICU – to better track patient conditions, helping the hospital achieve improved patient care, enhanced patient experience, lower costs and better staff satisfaction. The Intensive Care Unit (ICU) workflow is quite complex, involving admission/discharge, daily routine care, emergency, and unscheduled events, as well as managing end of life care. The sheer numbers of medications, scans, treatments, and tests administered pose a huge burden on patients and their loved ones, and the complex workflow demands a huge effort from all clinical teams involved. It is estimated there are 178 processes delivered to each ICU patient per day, with 1.7 of them associated with some error. For those teams, decision-making becomes a complex yet time-critical process, made even more difficult by data-overload caused by disparate devices, patient record systems and data sources. Digitization of healthcare services, especially in hospitals treating emergency and post-surgical patients, is a pressing need worldwide as hospitals cope with meeting surging healthcare demand while not compromising the quality of care and patient safety. As hospitals across the globe team with industry to improve and save lives, Indonesia is no exception. Acute care is particularly challenging, associated with the highest number of medical errors. Nearly all ICU patients suffer a potentially life-threatening error during their stay, with medication errors accounting for 78% of serious medical errors. Decision-making and diagnosis are also more difficult in critical care due to the vulnerability of patients, who can have co-morbidities and deteriorate rapidly.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Nanotronics Presents nSpec® High-Throughput System at Semicon Europa

Posted by fidest press agency su giovedì, 14 novembre 2019

München, Germany Friday, Nov. 15, 4pm B1139 Messegelände Nanotronics, the inventor of a platform for industrial inspection that combines AI, automation, and sophisticated imaging, will be exhibiting at SEMICON Europa.
“We will be exhibiting the nSpec® LS system,” says Julie Orlando, Chief Product Officer at Nanotronics. “This system is ideal for high-production manufacturing settings.” nSpec® LS includes a high-throughput option. At SEMICON Europa, Nanotroics engineers will demonstrate how AI recognizes defects and features of interest to streamline the inspection process.Nanotronics’ systems enable leading-edge technology companies to inspect semiconductors, next-generation 3D chips, innovative fabrics and materials, and more. Nanotronics aspires to improve yield and reduce waste by streamlining the inspection process.
Nanotronics invents platforms that combine robotics, sophisticated imaging, and advanced AI platforms to revolutionize process control for manufacturing and full-factory automation. Nanotronics develops artificial intelligence platforms expressly trained for the unique inspection needs of advanced industrial manufacturing.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Ra Medical Systems Announces Substantial Completion of Audit Committee Investigation

Posted by fidest press agency su lunedì, 4 novembre 2019

Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, today announced that the Audit Committee of the Board of Directors (the “Audit Committee”) has substantially completed its internal investigation, which was originally announced in August. The Audit Committee, assisted by independent legal counsel, Morrison & Foerster LLP, conducted a thorough investigation of allegations raised by an employee, as well as additional matters discovered during the course of the investigation.
The Audit Committee, in reviewing the allegations, identified certain behavior inconsistent with the Company’s Code of Ethics and Conduct and related policies involving certain current and former executive officers and employees of the Company. With respect to current Company executives and employees, the Audit Committee referred these matters to the Board or the Company for appropriate action and discipline.The Audit Committee made a number of recommendations which the Board of Directors has adopted, including: separation of certain employees, implementing additional and enhanced policies and training, strengthening the Company’s quality regulatory systems, and adopting certain enhanced controls related to the matters investigated.In addition, the Company has continued to take steps in an effort to improve the performance and reliability of the Company’s DABRA laser system, including hiring a VP, Quality, Regulatory and Clinical, conducting extensive internal and external audits of its quality systems, clinical trial data and manufacturing process, as well as initiating the previously announced voluntary recall of DABRA catheters.Based on the results of the investigation, the Company is in the process of evaluating the impact of the results of the investigation on its previously issued or announced financial statements, and its internal controls over financial reporting and compliance procedures.As previously disclosed, due to the Audit Committee investigation the Company has not filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019 (the “Form 10- Q”) with the SEC. The Company is working diligently to evaluate the Audit Committee investigation findings, including the assessment of the impact on the Company’s financial statements, if any, and its internal controls over financial reporting. After the conclusion of the Audit Committee investigation and the Company’s evaluation, the Company will file its Form 10-Q as soon as practicable thereafter.The Company notes that its physician customers continue to use the DABRA laser system with success, and the Company believes that the previously announced change in shelf life will significantly reduce the number of catheters that fail to calibrate and thereby improve customer satisfaction with the product. The Company is focusing its efforts on improving the manufacturing process, with the goals of improving product consistency and extending the shelf life.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Demonstration of China’s First Fuel Cell System in a 5G Telecom Application

Posted by fidest press agency su giovedì, 31 ottobre 2019

Element 1 Corp (“e1”), a leading developer of hydrogen generation technology, today announced that CO-WIN Hydrogen Power Company Limited (COWIN) has incorporated e1’s methanol-based hydrogen generation technology into a fuel cell system providing backup power to a 5G China Mobile 10kW telecom demonstration system in China. It is believed that this is the first fuel cell system incorporated into a 5G telecom application in China and possibly anywhere in the world. China Mobile, an active partner in the demonstration project, is the world’s largest mobile network operator with over 900 million subscribers. The demonstration system incorporates China Mobile 5G equipment and is located at the Tianhe Science Park in Guangzhou, China. This project is intended to support future commercial-scale utilization of hydrogen-based fuel cell power in 5G telecom systems throughout China and beyond.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

The CoFI System

Posted by fidest press agency su sabato, 26 ottobre 2019

CorFlow Therapeutics AG ( announced that the FDA has designated the company’s CoFI (CorFlow Controlled Flow Infusion) System as a “Breakthrough Device” with a broad indication-for-use statement: “The CoFI™System is indicated for diagnostic assessment of the coronary microcirculation immediately following PCI (“stenting”), and to be a platform for controlled infusion of therapeutic agents into the microcirculation with or without vessel occlusion.” This FDA designation is a process aimed at fast-forwarding clinical development and regulatory review of the CoFI™ System. Toward that end, CorFlow continues to enroll patients into the ongoing European “MOCA I” clinical trial of the CoFI™ System and will expedite US submissions for clinical trials as a result of the Breakthrough Designation. The MOCA I trial is a safety and feasibility trial in 40 acute heart attack patients.
Based on recent market research in the US and Europe, CorFlow estimates that more than 170,000 patients annually need new technologies to improve their coronary microcirculation after standard stent implantation. Although current stent technologies have proven to be crucial in saving patients from death and complications after a heart attack, these technologies do not address the unmet medical need for improved coronary microcirculation. Indeed, reduced coronary microcirculation has proven to be an independent marker for complications after a heart attack such as heart failure and death.The objective of the FDA Breakthrough Designation Program is to provide patients and healthcare providers with timely access to innovative medical devices by speeding their development, assessment and review, while preserving the standards for medical device approvals. CMS has also instituted a new rule that will increase payments for medical devices designated by the FDA as breakthrough devices.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy

Posted by fidest press agency su giovedì, 10 ottobre 2019

TORONTO and CAMBRIDGE, Mass., Oct. 08, 2019 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, has identified several novel antibody candidates for Multiple System Atrophy (MSA), a severe, Parkinson’s-like disease caused by toxic, misfolded forms of the protein alpha-synuclein. The new antibody candidates join ProMIS’ strong pipeline of antibodies that demonstrate high selectivity for toxic misfolded proteins, implicated as a root cause of several neurodegenerative diseases, including Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS).Our preclinical in vitro studies indicate that antibody candidates targeting toxic forms of alpha-synuclein bind strongly to toxic alpha-synuclein aggregates derived from MSA-affected brain. The same antibodies protect cultured neurons from alpha-synuclein toxicity and spreading (propagation). MSA is a rare, progressive disorder caused by loss of nerve cells in the brain; it affects approximately15,000 people in the United States. Scientific studies indicate that toxic oligomers and small soluble fibrils, derived from naturally occurring alpha-synuclein, are a root cause of disease development and progression in MSA. No disease-modifying treatments exist in part because traditional drug development methods are unable to generate antibodies that can target with precision the neurotoxic forms of alpha-synuclein. The ProMIS platform is a novel, proprietary method for discovering and developing antibodies that can uniquely and precisely target highly toxic misfolded proteins, also called toxic oligomers or prions, while preserving normal forms of the protein and normal protein function. The platform not only generates high-quality antibody candidates but also delivers powerful, validated candidates in months versus years.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Nuova realtà di system integration nel mondo delle comunicazioni mission-critical

Posted by fidest press agency su giovedì, 12 settembre 2019

L’operazione di merger avviata nel 2018, si è completata il 31 luglio 2019. A darne l’annuncio sono i membri del board, i legali rappresentanti Cesare Migani ed Elisabetta Cadonici, il Direttore Generale Sabrina Vescovi e il Direttore Vendite Fabio Cadonici. La nuova società metterà a fattor comune persone, competenze, prodotti e modello di go-to-market per dare vita a un nuovo operatore di riferimento in Italia nel settore della system integration ad alta specializzazione.

Posted in Economia/Economy/finance/business/technology | Contrassegnato da tag: , , , | Leave a Comment »

“Camera Positioning System, Method, and Apparatus for Capturing Images During a Medical Procedure”

Posted by fidest press agency su venerdì, 6 settembre 2019

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, announces that it has been granted U.S. Patent No. 10,398,287, titled “Camera Positioning System, Method, and Apparatus for Capturing Images During a Medical Procedure.” The patent is directed at aspects of the Company’s innovative dual-view camera system for use in robotic surgery, including single-port robotic surgery.Titan’s proprietary dual-view camera system consists of an endoscope module that incorporates a flexible 3D high-definition camera along with a light source and a camera insertion tube with an integrated 2D high-definition camera along with an independent light source. This innovative technology provides surgical teams with two high-definition options for visualizing the surgical field, which enhances efficiency and the safety of single-port robotic surgery. The newly granted patent is directed at the endoscope module, including its unique modular and flexible design. This design facilitates convenient camera docking and intra-operative access, providing the ability to clean the primary camera lenses during a surgical procedure without undocking from the robotic surgical system. Additional patent applications directed at other aspects of the dual-view camera system remain pending. With this patent grant and the Company’s latest patent filings, Titan now has 45 patents issued and 82 patent applications.Titan also announces that Intellectual Asset Management (“IAM”), a leading IP business media platform, named Jasminder Brar, the Company’s Director of Strategic Development and Intellectual Property, to the 2019 edition of IAM Strategy 300: The World’s Leading IP Strategists. This is the fifth consecutive year Mr. Brar has been recognized as a global intellectual property strategy leader.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Cubic to Deliver CBRND Collective Training Simulation System for Australian Army

Posted by fidest press agency su lunedì, 19 agosto 2019

Cubic Corporation (NYSE: CUB) today announced Cubic Defence New Zealand, which operates within its Cubic Global Defense business division, was selected to deliver a new simulation-enabled collective training capability, to better prepare soldiers for chemical, biological, radiological or nuclear defense (CBRND) missions. The capability will be delivered jointly by Cubic Defence Australia and New Zealand, expanding the offering for the Australian Army Combat Training Centre based in Townsville, North Queensland. The Cubic-developed CBRND training sub-system employs simulated CBRN threats projected within a synthetic environment to live instrumented soldiers in the exercise environment. “Cubic’s capability includes simulation of detection, casualty status, treatment and weather impacts,” said Miles Macdonald, general manager of Cubic Defence Australia and New Zealand. “The system is capable of projecting synthetic CBRN effects over large numbers of soldiers exercising on Australia’s training areas, enabling highly realistic scenarios to be exercised under simulated battlefield conditions.” “This training capability allows commanders and their units to experience the tactical and logistical impacts of operations in a CBRN threat environment,” added Macdonald. “It’s about enabling soldiers to realistically undertake threat identification, to test their mitigation and decontamination procedures and to understand the consequence of a threat and their own actions within the safety of a training environment.” The capability will be incorporated to the training activities available through the Combat Training Centre. Cubic is the market leader in providing live instrumented training capability to armed forces globally. Its training systems replicate the combat environment, allowing performance assessment and development of units and their commanders.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Global Drone Identification System Market Analysis 2019-2025

Posted by fidest press agency su giovedì, 15 agosto 2019

Drone Identification System market worldwide is projected to grow by US$71.1 Billion, guided by a compounded growth of 66%.Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments.Drone Mounting, one of the segments analyzed and sized in this study, displays the potential to grow at over 66.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$28.9 Billion by the year 2025, Drone Mounting will bring in healthy gains adding significant momentum to global growth.While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 77.9% growth momentum.
Within Europe, which continues to remain an important element in the world economy, Germany will add over US$6.5 Billion to the region’s size and clout in the next 5 to 6 years. Over US$2.5 Billion worth of projected demand in the region will come from other emerging Eastern European markets.In Japan, Drone Mounting will reach a market size of US$1.5 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 59.6% over the next couple of years and add approximately US$9.7 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Global Central Nervous System Diseases Drug Delivery Research Report 2019

Posted by fidest press agency su giovedì, 15 agosto 2019

The “Drug Delivery in Central Nervous System Diseases – Technologies, Markets & Companies” report from Jain PharmaBiotech has been added to Research AndMarkets. com’s offering. The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g., by intravenous injection) for targeted action in the CNS. The major challenge to CNS drug delivery is the blood-brain barrier (BBB), which limits the access of drugs to the brain substance.Advances in understanding of the cell biology of the BBB have opened new avenues and possibilities for improved drug delivery to the CNS. Several carrier or transport systems, enzymes, and receptors that control the penetration of molecules have been identified in the BBB endothelium. Receptor-mediated transcytosis can transport peptides and proteins across the BBB. Methods are available to assess the BBB permeability of drugs at the discovery stage to avoid development of drugs that fail to reach their target site of action in the CNS.Various strategies that have been used for manipulating the blood-brain barrier for drug delivery to the brain include osmotic and chemical opening of the blood-brain barrier as well as the use of transport/carrier systems. Other strategies for drug delivery to the brain involve bypassing the BBB. Various pharmacological agents have been used to open the BBB and direct invasive methods can introduce therapeutic agents into the brain substance.It is important to consider not only the net delivery of the agent to the CNS, but also the ability of the agent to access the relevant target site within the CNS. Various routes of administration as well as conjugations of drugs, e.g., with liposomes and nanoparticles, are considered. Some routes of direct administration to the brain are non-invasive such as transnasal route whereas others involve entry into the CNS by devices and needles such as in case of intrathecal and intracerebroventricular delivery.
Systemic therapy by oral and parenteral routes is considered along with sustained and controlled release to optimize the CNS action of drugs. Among the three main approaches to drug delivery to the CNS – systemic administration, injection into CSF pathways, and direct injection into the brain – the greatest developments is anticipated to occur in the area of targeted delivery by systemic administration.Many of the new developments in the treatment of neurological disorders will be biological therapies and these will require innovative methods for delivery. Cell, gene and antisense therapies are not only innovative treatments for CNS disorders but also involve sophisticated delivery methods. RNA interference (RNAi) as a form of antisense therapy is also described.The role of drug delivery is depicted in the background of various therapies for neurological diseases including drugs in development and the role of special delivery preparations. Pain is included as it is considered to be a neurological disorder. A special chapter is devoted to drug delivery for brain tumors. Cell and gene therapies will play an important role in the treatment of neurological disorders in the future.The method of delivery of a drug to the CNS has an impact on the drug’s commercial potential. The market for CNS drug delivery technologies is directly linked to the CNS drug market. Values are calculated for the total CNS market and the share of drug delivery technologies. Starting with the market values for the year 2017, projections are made to the years 2023 and 2028.The markets values are tabulated according to therapeutic areas, technologies and geographical areas. Unmet needs for further development in CNS drug delivery technologies are identified according to the important methods of delivery of therapeutic substances to the CNS. Finally suggestions are made for strategies to expand CNS delivery markets. Besides development of new products, these include application of innovative methods of delivery to older drugs to improve their action and extend their patent life.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Hyundai Mobis Develops South Korea’s First Camera Monitor System

Posted by fidest press agency su giovedì, 1 agosto 2019

The side-view mirror, which has been obstructing drivers from parking in narrow parking spaces, will be moving inside cars. Plus, the provision of a field of view significantly wider than the existing one and enablement of even more innovative design through the use of the space that used to house the side-view mirror are a bonus.
A camera monitor system is a device that monitors the driving behavior of cars coming from the posterolateral direction and displays the obtained information on monitors located inside your car based on camera sensors installed in the place of the side-view mirror. Not only does this technology increase driving safety by significantly reducing blind spots through provision of a wider field of view, but it also enables innovative changes to your car’s exterior design through the application of various types of cameras.The camera sensors’ field of view is about 35˚, which is more than twice that of the regular side-view mirror, around 17°. Therefore, the driver can drive safely without having to check blind spots by turning their head.Because monitors, a type of display device, are installed inside your car, a camera monitor system results in almost no protruding areas. This makes it possible to eliminate unexpected noises such as wind noise caused by the side-view mirror, and it also reduces air resistance, thereby improving fuel economy as well.The Camera Monitoring System (CMS) developed by Hyundai Mobis is designed to replace the side mirrors on both sides as well as the rear-view mirror, and therefore, it has stronger product competitiveness. The camera sensors, located on the left and right sides of the vehicle and under the rear shark fin antenna, recognize the rear and posterolateral driving environments and display them in real-time on monitors located inside the vehicle.
As the system is an important safety technology that monitors a car’s posterolateral driving environment, Hyundai Mobis has put special effort into verifying its reliability so that it can function normally even under severe conditions such as bad weather. Through that, Hyundai Mobis has secured a degree of reliability for the system sufficient enough for the driver to view the driving situation more clearly than with the naked eye in bad weather such as heavy rain or snow. In addition, Hyundai Mobis’s CMS has also satisfied all applicable laws and regulatory standards through testing by an authorized certification body.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Ceridian Named a Successful Supplier by the Government of Canada for a New Federal Pay System

Posted by fidest press agency su venerdì, 14 giugno 2019

Ceridian HCM Holding Inc. (NYSE: CDAY; TSX: CDAY), a global human capital management (HCM) technology company, is pleased to be named as a successful Gate 3 supplier by the Government of Canada. Following an innovative and agile procurement process, Ceridian will collaborate with the Government of Canada to co-design and deliver Next Generation HR and pay solutions for the federal public service.“Today, more than two million Canadians, or one in five private sector workers, rely on Ceridian to deliver their pay accurately and on-time,” said David Ossip, Chairman and CEO, Ceridian. “As a global technology company and an innovation leader in Canada, Ceridian has the deep expertise and the passion to restore operational effectiveness and trust in Canada’s federal pay system, which is responsible for paying more than 300,000 federal public servants.”Ceridian’s robust Dayforce platform manages the complex HCM requirements of large organizations around the world. Dayforce provides employees with modern, digital, and transparent workplace experiences and makes work life better for those who do the hard work of administering HR and payroll.“We believe that the greatest value, and the greatest opportunity for success, stems from collaboration with the people who will be using our solutions,” said Leagh Turner, President, Ceridian. “We look forward to continuing to work with the Government of Canada, unions and employees, to ensure our hard-working federal public servants are paid accurately and on-time every time – no surprises, no excuses, period.”

Posted in Estero/world news, Politica/Politics | Contrassegnato da tag: , , | Leave a Comment »

Kimberly Hartz Named New CEO of Washington Hospital Healthcare System

Posted by fidest press agency su mercoledì, 15 maggio 2019

The Washington Township Health Care District board has announced that Kimberly Hartz has been named Washington Hospital Healthcare System’s new Chief Executive Officer. Kimberly was selected following Nancy Farber announcing her plans to retire later this year.
Ms. Hartz has been with the Washington Hospital Healthcare System since 1994 and has served in numerous leadership roles, which includes her most recent position as Senior Associate Administrator for Ambulatory Care Services. In this capacity, she has had financial and operational oversight of strategic management, contracting, the neurosciences program, community relations, government relations, human resources, and various inpatient/outpatient ancillary services. Additionally, Ms. Hartz has had responsibility of the Washington Township Medical Foundation and the Development Corporation which includes the Washington Outpatient Surgery Center, Washington Outpatient Rehabilitation Center, Washington Medical Billing, Washington on Wheels, Washington Urgent Care, and Washington Sports Medicine. She was also instrumental in establishing and growing Washington Hospital’s affiliation with UCSF Health, which has brought academic-level care to the local community in the areas of the special care nursery, cancer care, inpatient pediatrics, genetic counseling, prenatal diagnostics, and cardiothoracic surgery. Ms. Hartz was also a critical player in two successful bond campaigns for general obligation bonds for Washington Hospital’s facilities master plan, which includes the recently opened Morris Hyman Critical Care Pavilion.“It has been a privilege to be a part of this amazing organization,” Hartz said. “Under Nancy’s remarkable leadership, we have become one of the nation’s best health care systems, and I am deeply honored to follow in her footsteps.” In addition to Ms. Hartz’ responsibilities with the Washington Hospital Healthcare System, she has been an active member of community nonprofit organizations. She is a member of the Niles Fremont Rotary Club (president 2011-12).Ms. Hartz’ education includes a Master of Science in management and industrial relations from Oxford University in England and a Bachelor of Arts in psychology from Stanford University.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

“Plasticoni 2019. Market-system’s animal and human”

Posted by fidest press agency su venerdì, 3 maggio 2019

Mantova Sabato 4 maggio ore 18.00 la Galleria Arianna Sartori di Mantova, nella sede di via Ippolito Nievo 10, inaugura la mostra “Plasticoni 2019. Market-system’s animal and human” dello scultore Mariano Pieroni, alla presenza dell’artista.
Per Mariano Pieroni è la prima personale nella Città di Mantova, dopo aver partecipato alla “Casa Museo Sartori” di Castel d’Ario alle rassegne: “L’arte italiana dalla terra alla tavola” nel 2015 con l’opera “Puledro” (scultura polimaterica, plasticone), “50anni d’Arte in Lombardia” nel 2016 con l’opera “Leviero 2” (scultura polimaterica, plasticone), “Animalia. Natura & Arte” nel 2017 con l’opera “Mandrillo” (scultura polimaterica, plasticone) e “ARTeSPORT” nel 2019 con l’opera “Tennista” (scultura in porcellana), esposizione curata da Arianna Sartori e che diventa l’occasione per approfondire il lavoro di questo artista affermato in Italia e all’estero.
Plasticoni 2019 Market-system’s animal and human vengono percepiti o interpretati come rappresentazioni Pop-Art, ma sono linguaggio simbolico che esprime un giudizio complesso, riferito al sistema filosofico-sociale mercantile attuale.Il massimo del kitsch, con le etichette ruffiane da cui siamo assediati in ogni ora della nostra giornata, è una provocazione indigesta quanto squillante, che, con il dilatarsi del tempo, si decanta e diventa storia.Perché PLASTICONI? Perché la plastica è il problema più grosso dell’inquinamento, che minaccia di trasformare il nostro pianeta in una discarica. Tutto questo è talmente evidente e semplice da apparire come una ovvietà. Pochi sentono l’urgenza di doversene fare carico personalmente. Mariano Pieroni è nato a Barga (Lu) il 17 giugno 1937, vive e opera a Solbiate Arno (Va). Orario dal Lunedì al Sabato 10.00-12.30 / 15.30-19.30 Chiuso festivi.

Posted in Cronaca/News, Mostre - Spettacoli/Exhibitions – Theatre | Contrassegnato da tag: , , , | Leave a Comment »

Oklahoma Specialty Hospital Selects the Evident Thrive EHR System

Posted by fidest press agency su giovedì, 2 maggio 2019

Evident LLC, a wholly owned subsidiary of CPSI (NASDAQ: CPSI) and a leading provider of electronic health record (EHR) systems and services, announced today that Oklahoma Spine Hospital, a specialty surgical hospital located in Oklahoma City, Oklahoma, has selected the cloud-hosted Thrive EHR solution to replace their existing system through a Software-as-a-Service (SaaS) payment model. They are expected to be live on Thrive by the fourth quarter of 2019.Oklahoma Spine Hospital started an EHR selection process when they were informed that their current vendor’s EHR was not certified to meet the requirements of the Promoting Interoperability Program. In order to meet their goal of attesting to CMS for the 2019 reporting period, they knew they had to explore other options. Once the search began, the team from Oklahoma Spine Hospital realized quickly that Evident was a good fit for them. The Evident Thrive solution will provide Oklahoma Spine Hospital with a level of external and internal interoperability they do not have, allowing providers to focus more on the patient and less on paperwork. Additionally, Evident’s proven track record with Oklahoma Spine Hospital’s sister facility, Black Hills Surgical Hospital, gave credibility to the Thrive EHR solution and the team from Evident.“While finding a certified EHR that would allow us to meet the 2019 reporting year requirements for the Promoting Interoperability Program instigated our search, we are gaining much more than that with Evident,” said Gary McCool, technology director of Oklahoma Spine Hospital. “We believe the functionality of the Thrive EHR will also lead to higher levels of patient satisfaction.” McCool added, “The deciding factor for us was being able to see the success that a similar specialty hospital is experiencing using Thrive. We are very happy with our decision and look forward to partnering with Evident for a long time to come.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Fentanyl Transdermal System Due to Product Mislabeling

Posted by fidest press agency su lunedì, 22 aprile 2019

Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level. A small number of cartons labeled 12 mcg/h Fentanyl Transdermal System patches contained 50 mcg/h patches. The 50 mcg/h patches that were included in cartons labeled 12 mcg/h are individually labeled as 50 mcg/h. This transdermal system is manufactured by 3M Drug Delivery Systems, St. Paul, MN.Application of a 50 mcg/h patch instead of a prescribed 12 mcg/h patch could result in serious, life threatening, or fatal respiratory depression. Groups at potential increased risk could include first time recipients of such patches, children, and the elderly. To date, Alvogen Inc. has not received any reports of adverse events related to this issue.The product is indicated for the management of pain in opioid tolerant patients and is packaged in primary cartons of five individually wrapped and labeled pouches. The affected Fentanyl Transdermal System lots include:
Lot 180060 of Fentanyl Transdermal System, 12 mcg/h, expiration date 05/2020.
Lot 180073 of Fentanyl Transdermal System, 12 mcg/h, expiration date 06/2020.
The mislabeled product is packaged in a 12 mcg/h primary carton. These lots of Fentanyl Transdermal System were distributed Nationwide to the pharmacy level.Alvogen Inc. is notifying its distributors and direct customers by certified letter and is arranging for return and replacement of all recalled products. Pharmacies are requested not to dispense any product subject to this recall. Patients that have product subject to this recall should immediately remove any patch currently in use and contact their health care provider. Patients with unused product should return it to point of purchase for replacement.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »